First Author, Publication Year (Ref) | Study Design | Size (n) | Spasticity Origin |
---|---|---|---|
Abbatemarco, 2020 (35) | Retrospective | 256 | Spinal (Multiple Sclerosis) |
Barney, 2020 (8) | Prospective non-RCT | 32 | Cerebral (Cerebral Palsy) |
Bayhan, 2016 (39) | Retrospective | 294 | Cerebral (Cerebral Palsy) |
Borowski, 2010 (S1) | Retrospective | 174 | Cerebral (Cerebral Palsy) |
Borrini, 2014 (S2) | Prospective non-RCT | 158 | Multiple (Cerebral and Spinal) |
Creamer, 2018 (27, S3) | RCT | 60 | Cerebral (Stroke) |
Dvorak, 2010 (S4) | Retrospective | 167 | Multiple (Cerebral and Spinal) |
Imerci, 2019 (40) | Retrospective | 341 | Cerebral (Cerebral Palsy) |
Khan, 2010 (S5) | Retrospective | 40 | Spinal (Multiple Sclerosis) |
Lee, 2018 (36) | Retrospective | 47 | Spinal (Multiple Sclerosis) |
Morton, 2011 (S6) | Prospective non-RCT | 38 | Cerebral (Cerebral Palsy) |
Motta, 2016 (38) | Retrospective | 508 | Multiple (Cerebral and Spinal) |
Motta, 2014 (S7) | Retrospective | 430 | Multiple (Cerebral and Spinal) |
Motta, 2011 (S8) | Retrospective | 30 | Cerebral (Cerebral Palsy) |
Natale, 2012 (4, S9) | Prospective non-RCT | 112 | Multiple (Cerebral and Spinal) |
Pucks-Faes, 2018 (37) | Retrospective | 116 | Multiple (Cerebral and Spinal) |
Ramstad, 2010 (S10) | Prospective non-RCT | 38 | Cerebral (Cerebral Palsy) |
Reis, 2019 (S11) | Retrospective | 155 | Multiple (Cerebral and Spinal) |
Sammaraiee, 2020 (29) | Prospective non-RCT | 30 | Spinal (Multiple Sclerosis) |
Sammaraiee, 2019 (7) | Prospective non-RCT | 106 | Spinal (Multiple Sclerosis) |
Schiess, 2020 (1) | Prospective non-RCT | 1,743 | Multiple (Cerebral and Spinal) |
Schiess, 2011 (28) | Prospective non-RCT | 30 | Cerebral (Stroke) |
ITB Studies | |||
Taira, 2013 (S12) | Retrospective | 400 | Multiple (Cerebral and Spinal) |
Vles, 2013 (S13–S15) | RCT (through 6-month) then Prospective non-RCT | 17 | Cerebral (Cerebral Palsy) |
Yoon, 2017 (34) | Prospective non-RCT | 37 | Cerebral (Cerebral Palsy and Brain Injury) |
BoNT A Studies | |||
Baricich, 2015 (32) | Retrospective | 26 | Cerebral (Stroke) |
Chaleat-Valayer, 2011 (S16) | Prospective non-RCT | 282 | Cerebral (Cerebral Palsy) |
Choi, 2019 (S17) | Retrospective | 591 | Cerebral (Cerebral Palsy) |
Clemenzi, 2012 (S18) | Prospective non-RCT | 21 | Cerebral (Brain Injury) |
Copeland, 2014 (S19) | RCT | 41 | Cerebral (Cerebral Palsy) |
Delgado, 2017 (S20) | Prospective non-RCT (extension of a previous RCT) | 216 | Cerebral (Cerebral Palsy) |
Demetrios, 2014 (S21) | Prospective non-RCT | 59 | Cerebral (Stroke) |
Dressler, 2015 (33) | Prospective non-RCT | 54 | Multiple (Cerebral and Spinal) |
Esquenazi, 2019 (17) | RCT | 468 | Cerebral (Stroke) |
Fheodoroff, 2020 (12, 16, 20) | Prospective non-RCT | 155 | Cerebral (Cerebral Palsy, Stroke, Brain Injury, Brain Tumour, Cerebral Vascular Disorders) |
Gonnade, 2018 (18) | RCT | 61 | Cerebral (Cerebral Palsy) |
Hara, 2018 (13) | Retrospective | 35 | Cerebral (Stroke) |
Hara, 2017 (31) | Retrospective | 51 | Cerebral (Stroke) |
Ianieri, 2018 (S22) | Retrospective | 120 | Multiple (Cerebral and Spinal) |
Intiso, 2014 (S23) | Prospective non-RCT | 22 | Cerebral (Cerebral Palsy and Brain Injury) |
Invernizzi, 2015 (21) | Prospective non-RCT | 11 | Cerebral (Stroke) |
Juneja, 2012 (S24) | Retrospective | 29 | Cerebral (Cerebral Palsy) |
BoNT A Studies | |||
Jung, 2011 (S25) | Prospective non-RCT | 27 | Cerebral (Cerebral Palsy) |
Kerzoncuf, 2020 (S26) | RCT | 40 | Cerebral (Stroke) |
Lannin, 2018 (S27) | Prospective non-RCT (feasibility randomized study) | 37 | Cerebral (Stroke) |
Maanum, 2011 (S28) | RCT | 66 | Cerebral (Cerebral Palsy) |
Roche, 2015 (S29) | RCT | 35 | Cerebral (Stroke) |
Safer, 2016 (S30) | Prospective non-RCT | 24 | Cerebral (Cerebral Palsy) |
Santamato, 2017 (S31) | Prospective non-RCT | 20 | Cerebral (Stroke) |
Santamato, 2013 (S32) | Prospective non-RCT | 25 | Cerebral (Stroke) |
Schramm, 2014 (S33) | Prospective non-RCT | 508 | Multiple (Cerebral and Spinal) |
Unlu, 2010 (S34) | Retrospective | 71 | Cerebral (Cerebral Palsy) |
RCT: randomized controlled trial